Aer Therapeutics

About:

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Website: https://aertherapeutics.com/

Top Investors: OrbiMed, Hatteras Venture Partners, Canaan Partners

Description:

Aer Therapeutics is a clinical-stage biopharmaceutical company that develops an approach to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as COPD, cystic fibrosis, and asthma.

Total Funding Amount:

$36M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

2014-01-01

Founders:

John Fahy

Number of Employees:

1-10

Last Funding Date:

2023-04-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai